Health Canada authorizes made-in-Canada COVID-19 vaccine
Health Canada has authorized a made-in-Canada COVID-19 vaccine from Medicago, known as Covifenz.The two-dose, plant-based vaccine is authorized for use in people aged 18 to 64.Health Canada says its effectiveness and safety in those under 18 and over 64 have ``not yet been established.''Clinical trials suggested the vaccine was 71 per cent effective in protecting against COVID-19 one week after the second dose. The dosing schedule is 21 days apart.Medicago, a biotechnology company based in Quebec City, along with GlaxoSmithKline, submitted Phase 3 data to Health Canada in December.The company ...
8.85 c|
